Scepticism greets new stem-cell regulations in China – BioEdge
BioEdge |
Scepticism greets new stem–cell regulations in China
BioEdge China's National Health and Family Planning Commission says that all stem cell treatments are deemed to be experimental, except for bone marrow transplants. There must be informed consent by the patient, clinical-grade stem cells must be used … |
